Maqic bullets for insomnia? Patients' use and experiences of newer (Z drugs) versus older (benzodiazepine) hypnotics for sleep problems in primary care

British Journal of General Practice

Volumn 58, Issue 551, 2008, Pages 417-422

  Siriwardena, A Niroshan ^a   Qureshi, M Zubair ^b   Dyas, Jane V ^c   Middleton, Hugh ^c   Orner, Roderick ^a  

^a UNIVERSITY OF LINCOLN   (United Kingdom)

^b South Park Surgery   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Attitude; Cross sectional studies; Hypnotics and sedatives; Prescriptions

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DIAZEPAM; HYPNOTIC AGENT; NITRAZEPAM; TEMAZEPAM; ZALEPLON; ZOLPIDEM; ZOPICLONE; ACETAMIDE DERIVATIVE; AZABICYCLO DERIVATIVE; HYPNOTIC SEDATIVE AGENT; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ADULT; AGED; ARTICLE; CONCENTRATION LOSS; CONFUSION; CONTROLLED STUDY; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG USE; FALLING; FEMALE; GENERAL PRACTICE; HEALTH SURVEY; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; PATIENT ATTITUDE; PRESCRIPTION; PRIMARY MEDICAL CARE; QUESTIONNAIRE; SHORT COURSE THERAPY; SIDE EFFECT; THOUGHT DISORDER; TREATMENT DURATION; UNITED KINGDOM; ADOLESCENT; ATTITUDE TO HEALTH; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; MIDDLE AGED; PATIENT SATISFACTION; WITHDRAWAL SYNDROME;

ACETAMIDES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; AZABICYCLO COMPOUNDS; BENZODIAZEPINES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PATIENT SATISFACTION; PIPERAZINES; PYRIDINES; PYRIMIDINES; SLEEP INITIATION AND MAINTENANCE DISORDERS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 44649098474     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp08X299290     Document Type: Article

References (35)

1. Chevalier H, Los F, Boichut D, et al. Evaluation of severe insomnia in the general population: results of a European multinational survey. J Psychopharmacol 1999; 13(4 Suppl 1): S21-S24.
2. Morphy H, Dunn KM, Lewis M, et al. Epidemiology of insomnia: a longitudinal study in a UK population. Sleep 2007; 30(3): 274-280.
3. Aikens JE, Rouse ME. Help-seeking for insomnia among adult patients in primary care. J Am Board Fam Pract 2005; 18(4): 257-261.
4. van der Hooft CS, Jong GW, Dieleman JP, et al. Inappropriate drug prescribirig in older adults: the updated 2002 Beers criteria - a population-based cohort study. Br J Clin Pharmacol 2005; 60(2): 137-144.
5. Dundar Y, Boland A, Strobl J, et al. Newer hypnotic drop for the short-term management of insomnia: a systematic review and economic evaluation. Health Technol Assess 2004; 8(24): iii-x, 1-125.
6. Holbrook AM. Treating insomnia. BMJ 2004; 329(7476): 1198-1199.
7. Department of Health. Prescription cam analysis (2005). http:// www.ic.nhs.uk/pubs/prescostanalysis2005 (accessed 1 May 2008).
8. National Statistics Online. Population change. Newport: National Office of Statistim 2007. http://www.statistics.gov.uk/cci/ nugget.asp?id=950 (accessed 6 May 2008).
9. Barnas C, Fleischhacker WW, Whitworth AB, et al. Characteristics of benzodiazepine long-term users: investigation of benzodiazepine consumers among pharmacy customers. Psychopharmacology (Berl) 1991; 103(2): 233-239.
10. King MB, Gabe J, Williams P, Rodrigo EK. Long term use of benzodiazepines: the views of patients. Br J Gen Pract 1990; 40(334): 194-196.
11. Lyndon RW, Russell JD. Benzodiazepine use in a rural general practice population. Aust N Z J Psychiatry 1988; 22(3): 293-298.
12. Bjorner T, Laerum E. Factors associated with high prescribing of benzodiazepines and minor opiates. A survey among general practitioners in Norway. Scand J Prim Health Care 2003; 21(2): 115-120.
13. Hamilton IJ, Reay LM, Sullivan FM. A survey of general practitioners' attitudes to benzodiazepine overprescribing. Health Bull (Edinb) 1990; 48(6): 299-303.
14. Mah L, Upshur RE. Long term benzodiazepine use for insomnia in patients over the age of 60: discordance of patient and physician perceptions. BMC Fam Pract 2002, 3: 9.
15. Iliffe S, Curran HV, Collins R, et al. Attitudes to long-term use of benzodiazepine hypnotics by older people in general practice: findings from interviews with service users and providers. Aging Ment Health 2004; 8(3): 242-248.
16. Siriwardena AN, Qureshi Z, Gibson S, et al. GPs' attitudes to benzodiazepine and 'Z-drug' prescribing a barrier to implementation of evidence and guidance on hypnotics. Br J Gen Pract 2006; 56(533): 964-967.
17. Dundar Y, Dodd S, Strobl J, et al. Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta analysis. Hum Pshychopharmacol 2004; 19(5): 305-322.
18. Barker MJ, Greenwood KM, Jackson M, Crowe SF. Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Arch Clin Neuropsychol 2004; 19(3): 437-454.
19. Glass J, Lanctrit KL, Herrmann N, et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 2005; 331(7531): 1169.
20. [No authors listed]. What's wrong with prescribing hypnotics? Drug Ther Bull 2004; 42(12): 89-93.
21. Morgan K, Clarke D. Longitudinal trends in late-life insomnia implications for prescribing. Age Ageing 1997, 26(3): 179-184.
22. Hajak G, Muller WE, Wittchen HU, et al. Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction 2003; 98(10): 1371-1378.
23. Mahoney JE, Webb MJ, Gray SL. Zolpidem prescribing and adverse drug reactions in hospitalized general medicine patients at a Veterans Affairs hospital. Am J Geriatr Pharmacother 2004; 2(1): 66-74.
24. Pompeia S, Lucchesi LM, Bueno OF, et al. Zolpidem and memory: a study using the process-dissociation procedure. Psychopharmacology (Berl) 2004; 174(3): 327-333.
25. Vermeeren A. Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs 2004, 18(5): 297-328.
26. Kripke DF. Greater incidence of depression with hypnotic use than with placebo. BMC Psychiatry 2007; 7: 42.
27. Morgan K. New theories for older problems. Sleep Med Rev 2006, 10(4): 211-213.
28. Holbrook AM, Crowther R, Lotter A. et al. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ 2000; 162(2): 225-233.
29. Stott NC, Davis RH. The exceptional potential in each primary care consultation. J R Coll Gen Pract 1979; 29(201): 201-205.
30. Montgomery P, Dennis J. A systematic review-of non-pharmacological therapies for sleep problems in later life. Sleep Med Rev 2004; 8(1): 47-62.
31. Morin CM, Hauri PJ, Espie CA, et al. Nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine review. Sleep 1999; 22(8): 1134-1156.
32. Lichstein KL, Wilson NM, Johnson CT. Psychological treatment of secondary insomnia. Psychol Aging 2000; 15(2): 232-240.
33. Espie CA, MacMahon KM, Kelly HL, et al. Randomized clinical effectiveness aid of nurse-administered small-group cognitive behavior therapy for persistent insomnia in general practice. Sleep 2007; 30(5): 574-584.
34. Petit L, Azad N, Byszewski A, et al. Non-pharmacological management of primary and secondary insominia among older people: review of assessment tools and treatments. Age Ageing 2003; 32(1): 19-25.
35. Sateia MJ, Nowell PD. Insomnia. Lancet 2004; 364(9449): 1959-1973.